Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-05-03

Clinical Trial Update: The Role of Central Venous Oxygen Saturation (ScvO2) as an Indicator of Blood Transfusion in the Critically Ill [NA]

View source ↗

Summary

An update on a clinical trial investigating whether central venous oxygen saturation (ScvO2) can guide blood transfusion decisions in critically ill patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Szeged University | Conditions: Blood Transfusion; Hemoglobinemia, Hypoxia | NA | Status: UNKNOWN